The purpose of this disclosure is to explain how we make money without charging you for our content.
Our mission is to help people at any stage of life make smart financial decisions through research, reporting, reviews, recommendations, and tools.
Earning your trust is essential to our success, and we believe transparency is critical to creating that trust. To that end, you should know that many or all of the companies featured here are partners who advertise with us.
Our content is free because our partners pay us a referral fee if you click on links or call any of the phone numbers on our site. If you choose to interact with the content on our site, we will likely receive compensation. If you don't, we will not be compensated. Ultimately the choice is yours.
Opinions are our own and our editors and staff writers are instructed to maintain editorial integrity, but compensation along with in-depth research will determine where, how, and in what order they appear on the page.
To find out more about our editorial process and how we make money, click here.
Earlier this month, we reported that Ebola.com’s owner, a disease-obsessed domain name vendor called Blue String Ventures, was hoping to sell the URL for at least $150,000. Now, according to a report from DomainInvesting.com, Ebola.com has been sold to a Russian company that is apparently focused on the marijuana business.
Filings with the Securities and Exchange Commission show Ebola.com was bought by Weed Growth Fund for $50,000 in cash and 19,192 shares of Cannabis Sativa, a Mesquite, Nevada-based recreational and medical marijuana company that trades on over-the-counter markets. Based on Cannabis Sativa’s current stock price, those shares are valued at roughly $164,000, making the overall transaction worth just over $200,000.
So to recap: Ebola.com was sold to a marijuana-related company based in Russia that paid mostly in the stock of another marijuana company.
But the story’s not over yet. As recently as September of this year, Weed Growth Fund was known as Ovation Research, which according to this BusinessWeek profile was in the business of distributing “stainless steel cookware products for retail and wholesale customers in North America.”
Then, on Sept. 19, the company filed with the Nevada Secretary of State changing its name to Weed Growth Fund. (We tried to contact Weed Growth Fund by phone and email to ask about the deal and name change, but got no answer.)
Why would a marijuana company want to own the URL Ebola.com? Elliot Silver, DomainInvesting.com’s publisher, asked Blue String Ventures founder Jon Schultz this very question. And while Schultz replied that he did not know why Weed Growth Fund wanted the domain, he did send Silver to this Marijuana.com article in which Cannabis Sativa CEO Gary Johnson (the former two-term New Mexico governor and Libertarian Party presidential candidate!) claims that marijuana can be used to treat Ebola. (You can see him do it in this Fox Business interview.) Cannabis Sativa also did not respond to requests for comment.
So there you have it. A newly renamed, Russian weed-related company bought Ebola.com using shares of a medical marijuana business run by a former Libertarian Party presidential candidate who thinks that pot should be used to treat Ebola. And no, you’re not high (as far as we know). This really happened.